BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 18, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 22, 2007
View Archived Issues
Combining tiotropium and fluticasone-salmeterol beneficial in COPD
Read More
AM-111 otoprotective in acute labyrinthitis model
Read More
Diverse immune responses seen with full-length p53 antigen-expressing vaccine
Read More
Myxoma virus: A novel viral oncolytic approach in hard to treat cancers
Read More
Targeted nanoparticles found effective in premalignant epithelial neoplasia
Read More
Interferon/gemcitabine-based adjuvant therapy improves survival, toxicity remains a concern
Read More
Zogenix closes USD 10 million financing deal
Read More
Enrollment completed in phase III Alzheimer's trial of Flurizan
Read More
CUV-1647 to be studied for prevention of phototoxicity in PDT
Read More
SPA filing for phase III study of Xyotax plus carboplatin in women with NSCLC
Read More
Pain Therapeutics cleared for Israeli phase I metastatic melanoma study
Read More
New data suggest utility of Homspera as cotherapeutic agent
Read More
Dharma's IDDS effective in reducing pain in phase II study
Read More
Updated interim antibody reduction data reported for Riquent
Read More
Cannasat and IntelGenx to codevelop novel cannabinoid-based product
Read More
Combination studies with sorafenib to continue after positive findings
Read More
Radius' hPTHrP analogue begins phase II testing for osteoporosis
Read More
Enrollment open in phase I/II study of plasmin for acute PAO
Read More
Potential applications for Unigene's site-directed bone growth technology
Read More
GenVec and NIAID sign CRADA for RSV vaccine development
Read More
Pharmatek to manufacture ANX-201 for clinical studies
Read More
No causal link between neuropsychiatric symptoms and treatment with Tamiflu
Read More
Aquavan provides successful sedation in patients undergoing bronchoscopy
Read More
Japanese approval for Risperdal OD
Read More
Novel agents are reported for use in the treatment of genitourinary disorders
Read More
Novel treatments for psychological disorders claimed in recent patents
Read More
